1887

Abstract

HIV prevalence in Oman is low (<5 %); however, 45 % of the population are expatriates, including a portion originating from countries with high HIV prevalence (>5 %). HIV screening is performed at regional public health laboratories as part of a medical fitness programme for residency applicants. We conducted a retrospective evaluation of indeterminate serology results from 11 females of African origin, aged 21–43 years. Serology testing for HIV was conducted according to the national Oman algorithm: fourth-generation immunoassays (Bio-Rad GS HIV Combo Ag/Ab EIA, Siemens Enzygnost HIV Integral 4, Abbott ARCHITECT HIV Ag/Ab Combo, Roche Elecsys HIV Combi PT, bioMérieux VIDAS HIV DUO QUICK), confirmatory assays (Geenius HIV 1/2 Confirmatory, INNO-LIA HIV I/II Score) and PCR testing. Confirmatory testing to resolve indeterminate results was conducted with available samples for five patients using a combination of immunoassays, confirmatory assays, PCR/PERT and pro-viral DNA levels, at three external laboratories; Roche Diagnostics (Germany), Swiss National Laboratory (Switzerland) and Barts Health NHS Trust (UK). Nineteen serum, 15 plasma and two whole-blood samples were analysed. Nine of ten patients analysed on Bio-Rad and Siemens immunoassays were highly reactive; seven were highly reactive on the Abbott assay. Eight of nine patients tested with the Roche assay were negative. Three of four patients tested on the bioMérieux assay were negative. Five patients underwent confirmatory testing at external laboratories; all were negative by HIV-RNA or pro-viral DNA testing. In conclusion, HIV-RNA and pro-viral DNA testing is recommended for HIV screening of individuals from high-prevalence regions coming to low-prevalence regions.

Funding
This study was supported by the:
  • Roche (Award N/A)
    • Principle Award Recipient: Not Applicable
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001186
2020-05-29
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/6/812.html?itemId=/content/journal/jmm/10.1099/jmm.0.001186&mimeType=html&fmt=ahah

References

  1. Ministry of Health HIV management in Oman. A guide for health care workers, 3rd edition. Muscat: Ministry of Health; 2015
    [Google Scholar]
  2. World Health Organization 2018; Prevalence of HIV among adults aged 15 to 49: estimates by country. http://apps.who.int/gho/data/view.main.22500?lang=en 24 August 2018
  3. Centers for Disease Control and Prevention 2014; Laboratory testing for the diagnosis of HIV infection: updated recommendations. https://stacks.cdc.gov/view/cdc/22423/cdc_22423_DS2.pdf 06 February 2020
  4. World Health Organization Service Delivery Approaches to HIV Testing and Counselling (HTC): A Strategic Policy Framework Geneva: World Health Organization; 2012
    [Google Scholar]
  5. World Health Organization Consolidated Guidelines on HIV Testing Services: 5Cs: Consent, Confidentiality, Counselling, Correct Results and Connection 2015 Geneva: World Health Organization; 2015
    [Google Scholar]
  6. Joshi RP, Gomez CA, Steiner D, Aziz N, Pinsky BA. The brief case: confirmed positive HIV-1 serologic screening but undetectable RNA virus load in a pregnant woman. J Clin Microbiol 2017; 55:3316–3320 [View Article][PubMed]
    [Google Scholar]
  7. Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS 2011; 6:163–168 [View Article][PubMed]
    [Google Scholar]
  8. Everett DB, Baisely KJ, McNerney R, Hambleton I, Chirwa T et al. Association of schistosomiasis with false-positive HIV test results in an African adolescent population. J Clin Microbiol 2010; 48:1570–1577 [View Article][PubMed]
    [Google Scholar]
  9. Voronin Y, Zinszner H, Karg C, Brooks K, Coombs R et al. HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians. Vaccine 2015; 33:1243–1249 [View Article]
    [Google Scholar]
  10. Kim S, Lee J-H, Choi JY, Kim JM, Kim H-S. False-positive rate of a "fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 2010; 17:1642–1644 [View Article][PubMed]
    [Google Scholar]
  11. Lang R, Charlton C, Beckthold B, Kadivar K, Lavoie S et al. HIV misdiagnosis: a root cause analysis leading to improvements in HIV diagnosis and patient care. J Clin Virol 2017; 96:84–88 [View Article][PubMed]
    [Google Scholar]
  12. Lavoie S, Caswell D, Gill MJ, Kadkhoda K, Charlton CL et al. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation architect HIV Ag/Ab Combo assay. J Clin Virol 2018; 104:23–28 [View Article][PubMed]
    [Google Scholar]
  13. Avidor B, Chemtob D, Turner D, Zeldis I, Girshengorn S et al. Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm. J Clin Virol 2018; 106:18–22 [View Article][PubMed]
    [Google Scholar]
  14. Delaney KP, Branson BM, Uniyal A, Phillips S, Candal D et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis 2011; 52:257–263 [View Article][PubMed]
    [Google Scholar]
  15. Mitchell EO, Stewart G, Bajzik O, Ferret M, Bentsen C et al. Performance comparison of the 4th generation Bio-Rad laboratories Gs HIV Combo Ag/Ab EIA on the EVOLIS automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur. J Clin Virol 2013; 58:e79–e84 [View Article][PubMed]
    [Google Scholar]
  16. Kosack CS, Page A-L, Beelaert G, Benson T, Savane A et al. Towards more accurate HIV testing in sub-Saharan Africa: a multi-site evaluation of HIV RDTs and risk factors for false positives. J Int AIDS Soc 2017; 19:21345 [View Article][PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001186
Loading
/content/journal/jmm/10.1099/jmm.0.001186
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error